Skip to main content

The Top 5 Analyst Questions From Altria’s Q1 Earnings Call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MO Cover Image

Altria’s first quarter saw a positive market response, as management credited moderating declines in smokeable product volumes and disciplined execution across its business lines for the strong results. CEO William Gifford pointed to the resilience of the Marlboro brand in the premium segment and highlighted the national rollout of on! PLUS nicotine pouches as significant contributors. Management also noted that enforcement actions curtailing illicit e-vapor products began to shift consumer demand back to legal offerings, with CFO Salvatore Mancuso emphasizing, “the moderation of cross-category movement between vapor and the cigarette category” as a key factor in the quarter’s performance.

Is now the time to buy MO? Find out in our full research report (it’s free for active Edge members).

Altria (MO) Q1 CY2026 Highlights:

  • Revenue: $4.76 billion vs analyst estimates of $4.57 billion (5.3% year-on-year growth, 4% beat)
  • Adjusted EPS: $1.32 vs analyst estimates of $1.25 (5.9% beat)
  • Adjusted EBITDA: $3.04 billion vs analyst estimates of $2.89 billion (63.9% margin, 5.2% beat)
  • Management reiterated its full-year Adjusted EPS guidance of $5.64 at the midpoint
  • Operating Margin: 62.1%, up from 39.6% in the same quarter last year
  • Market Capitalization: $117.2 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Altria’s Q1 Earnings Call

  • Mirza Faham Baig (UBS) asked why Altria did not raise its full-year guidance given the strong first quarter and inquired about drivers supporting the discount segment. CFO Salvatore Mancuso cited macroeconomic uncertainty and stronger smokeable performance but maintained a cautious stance on consumer pressures and gas prices.
  • Matthew Smith (Stifel) requested details on smokeable segment profitability and per-pack costs. Mancuso explained that strong pricing, higher volumes, and export activity drove performance, while reiterating investment timing and controllable cost benefits in the latest quarter.
  • Bonnie Herzog (Goldman Sachs) probed the phasing of duty drawback benefits and asked about Marlboro’s Cowboy Cut rollout. Mancuso confirmed benefits would increase through the year, attributing more balanced earnings growth to moderating volume declines, and described Cowboy Cut as a competitively priced option for price-sensitive Marlboro consumers.
  • Andrei Andon-Ionita (Jefferies) questioned drivers of Marlboro’s premium segment gains and early consumer adoption of on! PLUS. CEO Gifford credited Marlboro’s brand equity and data-driven pricing, while noting that on! PLUS is in early stages but positioned to benefit from flavor expansion pending FDA review.
  • Eric Serotta (Morgan Stanley) inquired about the macroeconomic impact on low-end consumers and implications of improved e-vapor enforcement. Mancuso highlighted elevated gas prices and increased tax refunds as near-term factors, while Gifford stressed that most e-vapor volume remains illicit, necessitating further regulatory action before expanding market participation.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will be monitoring (1) the nationwide adoption and retail performance of on! PLUS and progress on additional FDA authorizations for new flavors, (2) shifts in consumer behavior between premium, discount, and smoke-free categories as economic pressures evolve, and (3) the trajectory of regulatory enforcement against illicit vaping products and new state-level legislation. Continued execution on portfolio strategy and resilience to macroeconomic headwinds will also be key indicators.

Altria currently trades at $70.20, up from $68.20 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  271.17
-3.82 (-1.39%)
AAPL  287.44
-0.07 (-0.02%)
AMD  408.46
-12.93 (-3.07%)
BAC  52.75
-0.85 (-1.59%)
GOOG  395.30
+0.16 (0.04%)
META  616.81
+3.93 (0.64%)
MSFT  420.77
+6.81 (1.65%)
NVDA  211.50
+3.67 (1.77%)
ORCL  194.59
+0.56 (0.29%)
TSLA  411.79
+13.06 (3.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.